PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18676720-5	2008	The expression of adipocyte fatty acid binding protein (aP2) and adiponectin in myoblasts stably expressing porcine PPARgamma was increased when docosahexaenoic acid (DHA) was added to the adipogenic medium.	Docosahexaenoic Acids	145-165	fatty acid binding protein 4	Homo sapiens	56-59	
26754658-8	2016	Change in FABP4 level by omega-3 fatty acids was negatively correlated with change in levels of EPA + DHA (r = -0.643, P = 0.013), EPA (r = -0.540, P = 0.046) and DHA (r = -0.650, P = 0.011) but not change in the level of triglycerides or other fatty acid composition.	Docosahexaenoic Acids	102-105	fatty acid binding protein 4	Homo sapiens	10-15	
26754658-8	2016	Change in FABP4 level by omega-3 fatty acids was negatively correlated with change in levels of EPA + DHA (r = -0.643, P = 0.013), EPA (r = -0.540, P = 0.046) and DHA (r = -0.650, P = 0.011) but not change in the level of triglycerides or other fatty acid composition.	Docosahexaenoic Acids	163-166	fatty acid binding protein 4	Homo sapiens	10-15	
26754658-10	2016	However, gene expression and long-term (24 h) secretion of FABP4 were significantly reduced by treatment with EPA or DHA.	Docosahexaenoic Acids	117-120	fatty acid binding protein 4	Homo sapiens	59-64	
18676720-6	2008	The response was positively related to DHA concentration and suggests that DHA may bind to and activate porcine PPARgamma, leading to increased expression of aP2 and adiponectin.	Docosahexaenoic Acids	39-42	fatty acid binding protein 4	Homo sapiens	158-161	
18676720-6	2008	The response was positively related to DHA concentration and suggests that DHA may bind to and activate porcine PPARgamma, leading to increased expression of aP2 and adiponectin.	Docosahexaenoic Acids	75-78	fatty acid binding protein 4	Homo sapiens	158-161	
18676720-5	2008	The expression of adipocyte fatty acid binding protein (aP2) and adiponectin in myoblasts stably expressing porcine PPARgamma was increased when docosahexaenoic acid (DHA) was added to the adipogenic medium.	Docosahexaenoic Acids	167-170	fatty acid binding protein 4	Homo sapiens	56-59	
33663633-8	2022	The overexpression of fabp4 or PPARgamma increased the docosahexaenoic acid (DHA) content in hepatocytes, whereas suppression of their expression diminished this effect, suggesting that both fabp4 and PPARgamma play an active role in regulating DHA content.	Docosahexaenoic Acids	77-80	fatty acid binding protein 4	Homo sapiens	22-27	
33990655-6	2021	We finally tested our hypothesis on human Mesenchymal Stromal Cells differentiated to osteocytes and adipocytes confirming the beneficial effect of docosahexaenoic acid (DHA) omega-3 FA during treatment with rosiglitazone, through the down-regulation of adipogenic genes, such as adipsin and FABP4 along the PPARgamma/FABP4 axis, and reducing the capability of osteocytes to switch toward adipogenesis.	Docosahexaenoic Acids	148-168	fatty acid binding protein 4	Homo sapiens	292-297	
33990655-6	2021	We finally tested our hypothesis on human Mesenchymal Stromal Cells differentiated to osteocytes and adipocytes confirming the beneficial effect of docosahexaenoic acid (DHA) omega-3 FA during treatment with rosiglitazone, through the down-regulation of adipogenic genes, such as adipsin and FABP4 along the PPARgamma/FABP4 axis, and reducing the capability of osteocytes to switch toward adipogenesis.	Docosahexaenoic Acids	148-168	fatty acid binding protein 4	Homo sapiens	318-323	
33663633-0	2022	PPARgamma regulates fabp4 expression to increase DHA content in golden pompano (Trachinotus ovatus) hepatocytes.	Docosahexaenoic Acids	49-52	fatty acid binding protein 4	Homo sapiens	20-25	
33663633-8	2022	The overexpression of fabp4 or PPARgamma increased the docosahexaenoic acid (DHA) content in hepatocytes, whereas suppression of their expression diminished this effect, suggesting that both fabp4 and PPARgamma play an active role in regulating DHA content.	Docosahexaenoic Acids	55-75	fatty acid binding protein 4	Homo sapiens	22-27	
33663633-8	2022	The overexpression of fabp4 or PPARgamma increased the docosahexaenoic acid (DHA) content in hepatocytes, whereas suppression of their expression diminished this effect, suggesting that both fabp4 and PPARgamma play an active role in regulating DHA content.	Docosahexaenoic Acids	55-75	fatty acid binding protein 4	Homo sapiens	191-196	
33663633-8	2022	The overexpression of fabp4 or PPARgamma increased the docosahexaenoic acid (DHA) content in hepatocytes, whereas suppression of their expression diminished this effect, suggesting that both fabp4 and PPARgamma play an active role in regulating DHA content.	Docosahexaenoic Acids	245-248	fatty acid binding protein 4	Homo sapiens	22-27	
33663633-8	2022	The overexpression of fabp4 or PPARgamma increased the docosahexaenoic acid (DHA) content in hepatocytes, whereas suppression of their expression diminished this effect, suggesting that both fabp4 and PPARgamma play an active role in regulating DHA content.	Docosahexaenoic Acids	245-248	fatty acid binding protein 4	Homo sapiens	191-196	
33663633-9	2022	Moreover, the inhibition of fabp4 attenuated the increase in PPARgamma-mediated DHA content, and the overexpression of fabp4 alleviated this effect.	Docosahexaenoic Acids	80-83	fatty acid binding protein 4	Homo sapiens	28-33	
33663633-10	2022	Collectively, our findings indicated that fabp4, which is controlled by PPARgamma, plays an important role in DHA content regulation.	Docosahexaenoic Acids	110-113	fatty acid binding protein 4	Homo sapiens	42-47